Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „pembrolizumab“
Suchtreffer
Begriffe & Kennungen
Keytruda · 4.8 · Paediatric population Subcutaneous formulation The safety of pembrolizumab solution for injection for the trea
Eintrag öffnenKeytruda · 4.8 · Paediatric population The safety of pembrolizumab as monotherapy has been evaluated in 161 paediatric patients
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in combination with chemotherapy, radiation therapy (RT) or chemoradiotherapy (CRT) (see section
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in combination with chemotherapy, radiation therapy (RT) or chemoradiotherapy (CRT) (see section
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in combination with enfortumab vedotin (see section 4.2) When pembrolizumab is administered in c
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in combination with enfortumab vedotin (see section 4.2) When pembrolizumab is administered in c
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in combination with tyrosine kinase inhibitor (TKI) (see section 4.2) When pembrolizumab is admi
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in combination with tyrosine kinase inhibitor (TKI) (see section 4.2) When pembrolizumab is admi
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in monotherapy (see section 4.2) The safety of intravenous pembrolizumab as monotherapy has been
Eintrag öffnenKeytruda · 4.8 · Pembrolizumab in monotherapy (see section 4.2) The safety of pembrolizumab as monotherapy has been evaluated i
Eintrag öffnenKeytruda · 4.8 · Summary of the safety profile Pembrolizumab is most commonly associated with immune-mediated adverse reactions
Eintrag öffnenKeytruda · 4.8 · Summary of the safety profile Pembrolizumab is most commonly associated with immune-mediated adverse reactions
Eintrag öffnenKeytruda · 4.8 · Table 2: Adverse reactions in patients treated with pembrolizumab†
Eintrag öffnenKeytruda · 4.8 · Table 2: Adverse reactions in patients treated with pembrolizumab†
Eintrag öffnenKeytruda · 4.8 · Tabulated summary of adverse reactions Adverse reactions observed in clinical studies of pembrolizumab as mono
Eintrag öffnenKeytruda · 4.8 · The safety of intravenous pembrolizumab in combination with axitinib or lenvatinib in advanced RCC, and in com
Eintrag öffnenKeytruda · 4.8 · The safety of intravenous pembrolizumab in combination with chemotherapy, RT or CRT has been evaluated in 7 01
Eintrag öffnenKeytruda · 4.8 · The safety of intravenous pembrolizumab in combination with enfortumab vedotin has been evaluated among 167 pa
Eintrag öffnenKeytruda · 4.8 · The safety of intravenous pembrolizumab in combination with enfortumab vedotin has been evaluated among 564 pa
Eintrag öffnenKeytruda · 4.8 · The safety of pembrolizumab in combination with axitinib or lenvatinib in advanced RCC, and in combination wit
Eintrag öffnen